Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065182
Status:
COMPLETED
Last Update Posted:
2019-06-24
First Post:
2003-07-17
Brief Title:
Comparison of IV TopotecanDocetaxel to Docetaxel Alone in Second-Line Stage IIIBIV Non-Small Cell Lung Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2007-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2003-07-17
First Submit QC Date:
July 17 2003
Study First Post Date:
2003-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-06-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-29
Last Update Post Date:
2019-06-24
Last Update Post Date Type:
ACTUAL